Literature DB >> 30473711

Prevalence of HCV Infection in Household Contacts of Chronic Liver Diseases Cases in Egypt.

Hanaa E Bayomy Helal1, Abdelmoniem Yuonis1, Rania H M Shaker1, Mona Ahmed Elawady1.   

Abstract

Background: Egypt has the highest prevalence of HCV infection worldwide. This project aimed at identifying the role of HCV transmission among household contacts to index cases in the persistent high incidence of HCV infection in Egypt.
Methods: This cross-sectional study recruited 70 Egyptian cases with chronic liver diseases and their household contacts (140 contacts) from Qalubeyia Governorate. An interview questionnaire was used to collect information on sociodemographic characteristics and risk factors to HCV infection. HCV-RNA was tested using real-time polymerase chain reaction (PCR). Univariate and multivariate analyses were carried out to estimate the risk of HCV infection among contacts.
Results: HCV viremia was detected in 85.7% of cases and 20% of contacts. HCV-RNA was detected in higher proportion of household contacts to cases than the general population. Contacts to HCV-positive cases were unlikely exposed to used syringe (P=0.02) and unlikely to have history of Bilharziasis (P=0.001) compared to contacts to HCV-negative cases. HCV-positive contacts were more likely older (P < 0.001) and married (P=0.008) and had higher crowding index (P=0.04) than HCV-negative contacts. Also, HCV-positive contacts were more likely exposed to blood transfusion (P=0.008) and shaving at community barber (P=0.04) and had history of Bilharziasis (P=0.01). The strongest predictors for HCV infection among contacts were old age (OR, 95% CI: 1.08, 1.02 to 1.15; P=0.01) and blood transfusion (8.08, 1.75 to 37.3; P=0.007).
Conclusion: Nonetheless, household contacts to HCV cases are exposed to increased risk of HCV infection, and environmental exposure particularly blood transfusion remained a major source of HCV infection.

Entities:  

Mesh:

Year:  2018        PMID: 30473711      PMCID: PMC6220383          DOI: 10.1155/2018/2153537

Source DB:  PubMed          Journal:  J Environ Public Health        ISSN: 1687-9805


1. Introduction

In 2008, the Egyptian Demographic Health Survey reported that the prevalence of hepatitis C virus (HCV) infection was 14.7%, which was the highest prevalence of HCV in the world. [1] In 2013, the prevalence of HCV viremia was 7.3% due to the high mortality among old people with high prevalence of infection. [2] While in 2015, the prevalence of active HCV-infected cases was 4.4 [3]. A new era in the elimination of viral hepatitis has launched in 2015 when the United Nations General Assembly adopted the 2030 Agenda for Sustainable Development, which called on the international community to combat hepatitis. Viral hepatitis is a major public health challenge worldwide. The World Health Organization Eastern Mediterranean Region and the European Region have the highest reported prevalence of HCV particularly in the low- and middle-income countries. Globally, in 2015, the disease caused 1.34 million deaths. Each year, 1.75 million people newly acquire hepatitis C virus infection. These people are at risk of a slow progression to severe liver disease such as cirrhosis, hepatic decompensation, and hepatocellular carcinoma and death, unless they receive timely testing and treatment. [4]. Unsafe blood contact is the main source of HCV infection [5]. In Egypt, the main routes of HCV transmission have included the mass parenteral antischistosomal treatment from the 1950s to the 1980s, shared and reused needles, inadequate sterilization during dialysis, surgery, and dental care, and unsafe blood transfusion. Unsafe healthcare-related injections have been the major route of HCV transmission [6, 7]. Although the provision of safe injection practices was associated with reduced occurrence of HCV infection [8], the global incidence rate remained high (23.7 per 100,000) [4]. In Egypt, the prevalence of HCV infection is very high, and direct healthcare costs for hepatitis already consume 4% of the total health expenditure. Moreover, the indirect costs represent twice the direct costs. HCV treatment is highly cost-effective. That treating 328,000 HCV-infected patients annually by 2018 with the direct-acting antivirals (DAAs) could reduce the prevalence of infection by 94% and liver-related deaths by 75% by 2030 [9]. In Egypt, hepatitis C is just a problem in every family. The high prevalence of HCV infection and the clustering effect observed between HCV infections in households were linked to parenteral treatment for schistosomiasis [10]. However, the high incidence rate remained a pressing challenging to the already overstretched Egyptian healthcare system. Intrafamilial transmission has been accused for this high incidence. There are two patterns of intrafamilial transmission: horizontal transmission between patients infected with HCV and their household contacts sharing the same residential space due to shared behaviours and living conditions, and vertical transmission through the perinatal route. The perinatal transmission was found to have a minimal role [11, 12]. This project aimed to identify the role of intrafamilial transmission (transmission in relatives living in the same household) in the persistent high incidence of HCV infection in Egypt.

2. Subject and Methods

This cross-sectional study was conducted on cases with chronic liver diseases who were referred to the Molecular Biology Unit at Benha Faculty of Medicine, Qalubeyia Governorate, Egypt, to test for HCV infection and their household contacts. The field work was carried out over the period between September 2017 and February 2018. An approval from the Research Ethics Committee in Benha Faculty of Medicine was obtained to conduct this work. A written informed consent (in Arabic language) was obtained from all participants. It included all details about the study (title, objectives, methods, expected benefits and risks, and confidentiality of data).

1.1. Subjects

The least number of contacts was determined according to the following equation:where Z1−∝/2 is the standard normal variate at 5% type 1 error (P < 0.05); it is 1.96. P is the expected proportion based on previous studies (the prevalence of HCV viremia was 4.4% [3]). d is the absolute error (0.05). According to the above equation, the minimal sample size was calculated as 123 after allowance for double the prevalence of HCV viremia in household contacts compared to the general population [1]. The study recruited 140 contacts to 70 HCV-infected cases over the period of the study.

1.2. Inclusion Criteria

Cases with chronic liver diseases and aged ≥18 years old (to increase the likelihood of HCV infection) and their household contacts of both sexes and any age who were living in the same household with a case for at least one year were the candidates for the study.

1.3. Data Collection Tools

An interview questionnaire, which was reviewed and approved in previous studies [13-15], was used to collect information on personal data, socioeconomic characteristics, present and past health, and risk factors for exposure to HCV infection including history of surgical operations, dental procedures, blood transfusion, schistosomiasis treatment, contaminated needles or puncture, prior hospitalization, shared use of toothbrushes or shaving razors, common tools for nail trimming, circumcision, condom use, drug abuse, smoking, wet cupping (higama), tattooing, and multiple sexual partners. At the same visit, venous blood samples were collected to test for HCV-RNA using the quantitative real-time polymerase chain reaction (PCR). Extraction of viral RNA by the QIAamp Viral RNA mini kit was carried out using the QIAcube automatic extractor (QIAGEN GmbH). Amplification by TaqMan PCR master mix artus HCV RG RT-PCR kit (QIAGEN GmbH) was performed using the real-time PCR machine (Applied Biosystems StepOne Real-Time PCR System, San Diego, Ca, USA). A pilot study was undertaken on 10 subjects (including equal numbers of males and females), and their questionnaires were not included in the study. Testing of the questionnaire was useful in estimating the time taken to answer the questions and understanding of the questions. This helped to reduce limitations of understanding as well as nonresponse to questions.

1.4. Statistical Analysis

Mean ± standard deviation (SD) and range were used to describe quantitative data, and frequency and percentage were used to describe qualitative data. Comparisons between the different study groups were carried out using the chi-square test and the Fisher exact test to compare proportions as appropriate. The Student t-test was used to measure the mean difference between two groups regarding parametric data. Multiple logistic regression analysis for HCV-positive contacts conditioned on being a contact of an HCV case and other potential risk factors was carried out. The risk of HCV infection was presented as odds ratio (OR) and 95% confidence interval (CI). Statistical significance was accepted at P < 0.05. All statistical analyses were conducted using STATA/SE version 11.2 for Windows (STATA corporation, College Station, Texas).

3. Results

Study participants comprised 70 cases with chronic liver diseases, their ages ranged between 19 and 78 years with a mean of 49.5 ± 11.7 years, and males constituted 60% of them. HCV-RNA was detected in 60 cases (85.7%). Household contacts comprised 140 cases, their ages ranged between 3 and 75 years with a mean of 33.28 ± 16.75 years, and males constituted 40.71 % of them. HCV-RNA was detected in 28 households (20%). Detailed description of the characteristics of studied cases and their households and exposure to risk factors for HCV infection are shown in Table 1.
Table 1

Characteristics of the studied groups.

VariableCases (number = 70)Household contacts (number = 140)VariableCases (number = 70)Household contacts (number = 140)
Number%Number%Number%Number%
SexFemales2840.08359.29History of blood transfusionNo5984.2912790.71
Males4260.05740.71Yes1115.71139.29
Age (years)Mean ± SD (range)49.51 ± 11.71 (19–78)33.28 ± 16.75 (3–75)Priossr surgical proceduresNo22.861611.43
OccupationHousewife811.433927.86Yes6897.1412488.57
Specialist4462.864532.14Prior hospitalizationNo4057.149870.0
Medical/paramedical68.5753.57Yes3042.864230.0
Student22.864330.71CircumcisionBy medical personnel68.572719.29
Worker1014.2985.71By nonmedical personnel6390.08963.57
Educational levelIlliterate11.4375.0No11.432417.14
Read and write3144.298963.57Condom useNo6897.1413898.57
Basic education811.432014.29Yes22.8621.43
Secondary school57.14117.86Shaving at community barber (males only)No710.005942.14
High education2535.71139.29Yes6390.008157.86
Marital statusSingle45.715035.71Nail trimmingPrivate tool2231.432719.28
Married6592.869064.29Common tools4868.5711380.71
Widow11.4300.0Smoking ShishaNo6085.7113495.71
ResidenceUrban6085.7111884.29Yes1014.2964.29
Rural1014.292215.71Sharing razorsNo2434.296042.86
Relation to casesPartners3726.43Yes4665.718057.14
Parents96.43Exposed to used syringe∗∗No2434.294632.86
Sons7251.43Yes4665.719467.14
Siblings139.29Exposed to used toothbrushNo6085.7112287.14
Others96.43Yes1014.291812.86
Crowding index (persons/room)Mean ± SD (range)1.16 ± 0.66 (0.3–3)Practice of tattooingNo5680.012690.0
HCV-RNANegative1014.2911280.0Yes1420.01410.0
Positive2332.86128.57Exposed to bloodNo5477.1411481.43
UD3752.861611.43Yes1622.862618.57
SymptomsDiarrhea1521.43History of BilharziasisNo5477.1412891.43
Abdominal pain3550.0Yes1622.86128.57
Easy fatigue3042.86No5477.1413294.29
Yellow sclera912.86History of injection treatment for BilharziasisYes1622.8685. 71
Dark urine912.86

UD: undetermined; below detection level in patients who were under treatment for HCV; more than one symptom was allowed; this included IV, IM, and needle stick injury.

Figure 1 shows the results of real-time PCR, and 6 out of 16 household contacts to HCV-negative cases (37.5%) had HCV viremia. While 22 out of 124 household contacts to HCV-positive cases (17.74%) had HCV viremia. However, this difference was nonsignificant (OR, 95% CI: 0.36, 0.1 to 1.35, and P=0.09).
Figure 1

Relationship between studied cases and household contacts regarding the HCV infection.

Table 2 shows comparisons between household contacts to cases with HCV infection and those contacts to cases without HCV infection. Household contacts to HCV-positive cases were less likely to be exposed to used syringe than contacts to HCV-negative cases (0.12, 0.003 to 0.82, and P=0.02). Household contacts with history of Bilharziasis were less likely among contacts to HCV-positive cases compared to contacts to HCV-negative cases (0.08, 0.02 to 0.39, and P=0.001).
Table 2

Comparison between household contacts to HCV-positive cases and household contacts to HCV-negative cases.

VariableHousehold contacts to HCV-positive/UD cases (number = 124)Household contacts to HCV-negative (number = 16)OR (95% CI)VariableHousehold contacts to HCV-positive/UD cases (number = 124)Household contacts to HCV-negative (number = 16)OR (95% CI)
Number%Number%Number%Number%
SexFemales5141.13637.50.86 (0.24–2.81)Condom useNo12298.3916100.0
Males7358.871062.50Yes21.6100.0
Age (years)Mean ± SD (range)32.89 ± 16.74 (3–75)36.25 ± 17.07 (12–62) P=0.45aShaving at community barber (males only)No5141.13850.01.43 (0.43–4.68)
OccupationHousewife3629.03318.751.00Yes7358.87850.0
Specialist3830.65743.750.45 (0.07–2.19)CircumcisionBy medical personnel2217.74531.251.00
Medical/paramedical43.2316.250.33 (0.02–21.82)By nonmedical personnel7963.711062.501.79 (0.43–6.49)
Student3830.65531.251.4 (0.34–6.09)No2318.5516.255.23 (0.51–257.73)
Worker86.4500.0
Educational levelIlliterate/read and write8366.941381.251.00Nail trimmingPrivate tool9879.031593.753.98 (0.56–173.85)
Basic/secondary education3024.1916.254.70 (0.65–206.20)
High education118.87212.500.86 (0.16–8.88)Common tools2620.9716.25
Marital statusUnmarried4536.29531.250.80 (0.20–2.69)Smoking shishaNo11995.971593.750.63 (0.06–31.77)
Married7963.711168.75Yes54.0316.25
ResidenceUrban10383.061593.753.06 (0.42–134.77)Sharing razorsNo5241.94850.01.38 (0.42–4.53)
Rural2116.9416.25Yes7258.06850.0
Relation to casesPartners97.2600.01.00Exposed to used syringeNo4536.2916.25 0.12 (0.003–0.82)
Parents3024.19743.750 (0–2.03)Yes7963.711593.75
Sons6653.23637.500 (0–5.17)Exposed to used toothbrushNo10685.4816100.0
Siblings108.06318.750 (0–1.71)Yes1814.5200.0
Others97.2600.0Practice of tattooingNo10887.101487.501.04 (0.20–10.24)
Crowding index (person/room)Mean ± SD (range)1.15 ± 0.7 (0.28–3)1.1 ± 0.5 (0.6–1.67) P=0.78aYes1612.90212.50
History of blood transfusionNo11189.5216100.0Exposed to bloodNo10282.261275.000.65 (0.17–3.02 A)
Yes1310.4800.0Yes2217.74425.00
Prior surgical proceduresNo1512.1016.250.48 (0.01–3.64)History of BilharziasisNo11895.161062.50 0.08 (0.02–0.39) ∗∗
Yes10987.901593.75Yes64.84637.50
Prior hospitalizationNo8669.351275.001.32 (0.37–5.99)History of injection treatment for BilharziasisNo11794.351593.750.90 (0.10–43.10)
Yes3830.65425.00Yes75.6516.25

UD: undetermined; below detection level in patients who were under treatment for HCV; aStudent t-test; P: probability; OR (95% CI): odds ratio (95% confidence interval); P < 0.05; P < 0.01.

Comparisons between HCV-positive and HCV-negative household contacts were carried out as shown in Table 3. HCV-positive contacts were more likely older (P < 0.001) and married (P=0.008) and had higher crowding index (P=0.04). HCV-positive contacts were more likely exposed to blood transfusion (P=0.005) and shaving at community barber (P=0.04) and had history of Bilharziasis (P=0.01).
Table 3

Comparison between HCV-positive and HCV-negative household contacts.

VariableHCV-positive/UD (number = 28)HCV-negative (number = 112)OR (95% CI)VariableHCV-positive/UD (number = 28)HCV-negative (number = 112)OR (95% CI)
Number%Number%Number%Number%
SexFemales1450.06961.611.60 (0.64–4.01)Condom useNo28100.011098.210 (0–7.84)
Males1450.04338.39Yes00.021.79
Age (years)Mean ± SD (range)47.96 ± 13.87 (16–75)29.58 ± 15.36 (3–65) P < 0.001aShaving at community barber (males only)No725.005246.43 2.6 (0.96–7.79)
OccupationHouse wife725.03228.571.00Yes2175.06053.57
Specialist1657.142925.892.52 (0.83–8.25)CircumcisionBy medical personnel414.292320.541.00
Medical/paramedical13.5743.571.14 (0.02–14.19)By nonmedical personnel2278.576759.821.89 (0.55–8.29)
Student13.574237.5 0.11 (0.002–0.94) No27.142219.640.52 (0.04–4.13)
Worker310.7154.462.74 (0.34–18.08)
Educational levelIlliterate/read and write1967.867768.751.00Nail trimmingPrivate tool414.292219.641.47 (0.44–6.39)
Basic/secondary education621.432522.320.97 (0.28–2.91)Common tools2485.719080.36
High education310.71108.931.21 (0.19–5.36)
Marital statusUnmarried414.294641.07 4.18 (1.30–17.54) ∗∗ Smoking shishaNo2796.4310795.540.79 (0.02–7.53)
Married2485.716658.93Yes13.5754.46
ResidenceUrban2278.579685.711.64 (0.47–5.05)Sharing razorsNo932.145145.541.76 (0.69–4.82)
Rural621.431614.29Yes1967.866154.46
Relation to casesPartners932.142825.001.00Exposed to used syringeNo828.573833.931.28 (0.48–3.69)
Parents621.4332.68 6.22 (1.02–44.40) Yes2071.437466.07
Sons310.716961.61 0.13 (0.02–0.60) ∗∗ Exposed to used toothbrushNo2692.869685.710.46 (0.05–2.18)
Siblings932.1443.57 7.00 (1.45–37.43) ∗∗ Yes27.141614.29
Others13.5787.140.39 (0.01–3.72)Practice of tattooingNo2796.439988.390.28 (0.01–2.05)
Crowding index (person/room)Mean ± SD (range)1.9 ± 0.6 (0.3–3)1.67± 0.5 (0.3–3) P =0 .0 4 a Yes13.571311.61
History of blood transfusionNo2175.010694.64 5.89 (1.50–23.18) ∗∗ Exposed to bloodNo1967.869786.61 3.06 (1.01–8.75)
Yes725.065.36Yes932.141513.39
Prior surgical proceduresNo310.711311.611.09 (0.27–6.43)History of BilharziasisNo2278.5710694.64 4.82 (1.15–19.63)
Yes2589.299988.39Yes621.4365.36
Prior hospitalizationNo1657.148273.212.05 (0.78–5.23)History of injection treatment for BilharziasisNo2589.2910795.542.57 (0.37–14.11)
Yes1242.863026.79Yes310.7154.46

UD: undetermined; below detection level in patients who were under treatment for HCV; aStudent t-test; P: probability; OR (95% CI): odds ratio (95% confidence interval); P < 0.05; P < 0.01.

Multiple logistic regression analysis for being HCV-positive household contacts conditioned on exposure to a HCV-positive case and other potential risk factors was carried out (Table 4). Contacts to HCV-positive cases were less likely to be HCV infection (OR, 95% CI: 0.14, 0.02 to 0.75, and P=0.02). However, the risk of being HCV-positive was increased with the increase in age (1.08, 1.02 to 1.15, and P=0.01) and among contacts who had blood transfusion (8.08, 1.75 to 37.3, and P=0.007).
Table 4

Logistic regression of being HCV-positive household contact conditioned on exposure to HCV-positive cases, relation to cases, age, educational level, and history of blood transfusion.

VariableOR95% CI P
HCV-positive cases vs. HCV-negative cases 0.140.02–0.750.02
Relation to case
Partners1.00
Parents11.351.65–77.900.01
Sons1.260.16–10.150.83
Siblings15.332.80–83.750.002
Others1.220.06–23.210.89
Age (years) 1.081.02–1.150.01
Educational level
Illiterate/read and write1.00
Basic/secondary education6.141.20–31.280.03
High education1.520.20–11.390.68
History of blood transfusion
Yes vs. no8.081.75–37.300.007

OR: odds ratio; 95% CI: 95% confidence interval; P: probability.

4. Discussion

4.1. HCV Infection Remained the Main Cause of Chronic Liver Diseases

This cross-sectional study was conducted to determine the prevalence of hepatitis C infection among household contacts to infected cases. The study examined 70 patients with chronic liver disease, of whom 60 were infected with chronic hepatitis C and 10 had liver disease due to causes other than HCV infection. In addition, 140 household contacts of the chronic liver diseases cases were included, of these 124 were contacts to the HCV cases (2.07 contacts per case), and 16 were contacts to the HCV‐negative cases (1.6 contacts per case). The results of the study revealed that HCV infection remained the main cause of chronic liver diseases with a prevalence rate of 85.7% among cases, while the overall prevalence of HCV in the household contacts of both cases and controls was 20%. Of the household contacts of HCV-infected patients, 22 out of the 124 contacts were HCV viremic (17.7%), compared to 6 out of the 16 contacts of HCV-negative cases (37.5%). The prevalence in both groups of contacts is much higher than the prevalence in the general population, which in similar age groups is in the range of 4%-5% viremic prevalence [3, 16]. This might suggest an increased risk of HCV infection among contacts to HCV-infected cases who serve as reservoirs of infection to their household contacts. This was also suggested by previous studies in Egypt [17, 18]. A prospective cohort of 6,734 anti-HCV-negative rural Egyptians detected 33 seroconversions. The strongest predictor for seroconversions was having anti-HCV-positive family member [17]. A comparative study of Egyptian families which included 90 families with index HCV-positive case (257 contacts) and 38 families with no index case (75 contacts) reported that 32 out of the 90 families with index cases had one or more HCV-positive contacts (38/257; 14.8%), while only two families with no index cases had HCV-positive contacts (3/75; 4%). Hence, intrafamilial transmission was thought to be a major underlying factor to the high prevalence of HCV infection in Egypt [18]. Regarding viremic contacts of HCV-negative cases, the six contacts had past history of hospitalization, surgical procedures, and exposure to used syringe and were circumcised by nonmedical personnel, and three of them had past history of injection treatment for Bilharziasis (unpresented data). These increased the proportion of viremic contacts of HCV-negative cases.

4.2. HCV-Positive Household Contacts Were More Likely in Sexual Partners and Siblings

In the present study, HCV-positive household contacts were more likely in sexual partners and siblings. HCV positivity was more frequent in older, married contacts with higher crowding index. This corresponds to findings reported by concurrent studies in Egypt, which linked the familial transmission of HCV with advanced age (≥40) and sexual partners [18, 19]. Correspondingly, a cross-sectional study of 175 Italian HCV-positive patients and their family members found that HCV-positive family members accounted for 8.9% (23/259) with the highest prevalence in sexual partners (12.1%). The prevalence of anti-HCV was more likely in older family contacts [20]. Again in Italy over the period from 1975 to 2003, a total number of 2856 of HCV-infected index cases were invited with their family members (number =13,440) to take part in a study to investigate risk factors for HCV transmission. The overall prevalence of HCV infection in family members was 2.1%, with the highest prevalence in sexual partners (13.8%) followed by offspring (2.3%) and parents and siblings (2.1%) [21]. However, there were no significant differences in the prevalence of HCV infection between contacts to HCV-positive and HCV-negative cases. This contradicts the above suggestion. But, the high prevalence of HCV infection among contacts to HCV-negative patients could be explained by the past history of hospitalization, surgical procedures, exposure to used syringe, circumcision by nonmedical personnel, and prior injection treatment for Bilharziasis. Moreover, it was found that HCV-positive contacts were more likely exposed to sources of infections such as shaving at common barber, infected blood, and Bilharziasis. Thus, the risk of HCV infection increased with environmental exposure to potential sources of infection. Correspondingly, the risk of HCV infection was increased among sexual partners of the Italian index cases who were intravenous drug users (23.6%) compared to cases who acquired infection through transfusions (7.8%), which suggests a parenteral route of transmission [21]. In addition, a controlled historical cohort study was conducted in Iran to investigate the intrafamilial transmission of HCV infection among sexual and nonsexual contacts. Only 2.9% (7/270 subjects) of contacts to HCV cases and 1.1% (3/270 subjects) of contacts to noninfected controls had anti-HCV antibodies. Of these, two subjects among the unexposed group proved to be HCV-infected during the recombinant immunoblot assay (RIBA) and PCR, and both of them were IV drug users. Thus, there was no intrafamilial risk for HCV transmission, and sexual contact was more likely to stimulate the immune system rather than increasing the risk of HCV infection [22]. Moreover, in the present study, we found that risky behaviours such as using nonsterile syringes and exposure to Bilharzial infection were less frequent among household contacts to HCV-infected case. This might reflect their awareness about the ways of HCV transmission. In this study, HCV infection in household contacts to index cases was associated with past history of blood transfusion. However, in this study, whether this transfusion was before or after blood donor screening policy was not verified, but still blood transfusion represents a main risk for HCV infection, which emphasizes more efforts for safe blood transfusion. Similarly, 72% of subjects with history of blood transfusion (54/75 subjects) were HCV positive in the cross-sectional survey of one thousand healthy blood donors volunteered in Kaser Al Ani hospital blood bank, Cairo, Egypt [23]. Correspondingly, transfusion was commonly reported as the main rout of HCV transmission among blood donors in Iran [24, 25] and in USA [26], in asymptomatic urban population of the State of Mexico with at least one risk factor [27], and in HCV-infected patients who were identified between 2001 and 2008 in the Northern California, USA [28]. However, in Egypt, the main risk factor for HCV infection was the traditional injection treatment of schistosomiasis [29-31].

4.3. Limitations

The main limitations of this study were the unknown duration of the disease for index case and recall bias due to the cross-sectional nature of the study, which also makes it inaccessible to assess the time relationship between exposure to risk factors including the index case and outcome (HCV seropositivity) unlike the prospective cohort design. Further large-scale prospective studies to investigate the viral sequencing between cases and contacts (seroconversion) are recommended to prove or disprove the contact transmission. As far as information bias is concerned, this type of error could be avoided by using a well-established means of collecting data on past exposures and risk factors. Regarding selection bias, we collected information regarding the contacts of the index patients attending Benha Faculty of Medicine, and we believe that our population is a random sample of patients with HCV. Another limitation of the study refers to the lack of assessment for HCV genotypes, so we were unable to address whether family members share the same genotype, and differing genotypes have differing rates of transmission.

5. Conclusion

The controversy on the intrafamilial transmission of HCV infection can be due to the different methods used to detect anti-HCV antibodies (first and second generations ELISA have lower sensitivity than the third-generation assays), different geographic areas, viremia levels, and sexual behaviours of the target population. Finally, it can be concluded that household contacts to HCV cases are exposed to increased risk of HCV infection. This is favoured by environmental exposures to other sources of infections. Nonetheless, contacts to HCV patients are more likely aware of the different ways of HCV transmission and avoid exposure to sources of infection. In addition, prolonged exposure to infected cases can stimulate the immune system.
  26 in total

1.  Risk factors associated with hepatitis C virus infection in an urban population of the State of Mexico.

Authors:  S Romero-Figueroa; E Ceballos-Salgado; L Santillán-Arreygue; M Miranda-García; M Rubio-Lezama; J J Garduño-García
Journal:  Arch Virol       Date:  2011-10-30       Impact factor: 2.574

2.  Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women.

Authors:  Sonia K Stoszek; Mohamed Abdel-Hamid; Shaker Narooz; Mai El Daly; Doa'a A Saleh; Nabiel Mikhail; Enas Kassem; Yousry Hawash; Sherif El Kafrawy; Ahmed Said; Manal El Batanony; Fatma M Shebl; Mohamed Sayed; Soraya Sharaf; Alan D Fix; G Thomas Strickland
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-11-09       Impact factor: 2.184

3.  Hepatitis C virus acquisition among Egyptians: analysis of a 10-year surveillance of acute hepatitis C.

Authors:  Amira Mohsen; Adeline Bernier; Lenaig LeFouler; Elisabeth Delarocque-Astagneau; Mai El-Daly; Sherif El-Kafrawy; Salwa El-Mango; Mohamed Abdel-Hamid; Mohsen Gadallah; Gamal Esmat; Mostafa K Mohamed; Arnaud Fontanet
Journal:  Trop Med Int Health       Date:  2014-10-22       Impact factor: 2.622

4.  Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre.

Authors:  Sayed Abdelwahab; Eman Rewisha; Mohamed Hashem; Maha Sobhy; Iman Galal; Walaa R Allam; Nabeil Mikhail; Gehan Galal; Mohamed El-Tabbakh; Samer S El-Kamary; Imam Waked; G Thomas Strickland
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-12-22       Impact factor: 2.184

5.  The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Authors:  H Razavi; I Waked; C Sarrazin; R P Myers; R Idilman; F Calinas; W Vogel; M C Mendes Correa; C Hézode; P Lázaro; U Akarca; S Aleman; I Balık; T Berg; F Bihl; M Bilodeau; A J Blasco; C E Brandão Mello; P Bruggmann; M Buti; J L Calleja; H Cheinquer; P B Christensen; M Clausen; H S M Coelho; M E Cramp; G J Dore; W Doss; A S Duberg; M H El-Sayed; G Ergör; G Esmat; K Falconer; J Félix; M L G Ferraz; P R Ferreira; S Frankova; J García-Samaniego; J Gerstoft; J A Giria; F L Gonçales; E Gower; M Gschwantler; M Guimarães Pessôa; S J Hindman; H Hofer; P Husa; M Kåberg; K D E Kaita; A Kautz; S Kaymakoglu; M Krajden; H Krarup; W Laleman; D Lavanchy; R T Marinho; P Marotta; S Mauss; C Moreno; K Murphy; F Negro; V Nemecek; N Örmeci; A L H Øvrehus; J Parkes; K Pasini; K M Peltekian; A Ramji; N Reis; S K Roberts; W M Rosenberg; F Roudot-Thoraval; S D Ryder; R Sarmento-Castro; D Semela; M Sherman; G E Shiha; W Sievert; J Sperl; P Stärkel; R E Stauber; A J Thompson; P Urbanek; P Van Damme; I van Thiel; H Van Vlierberghe; D Vandijck; H Wedemeyer; N Weis; J Wiegand; A Yosry; A Zekry; M Cornberg; B Müllhaupt; C Estes
Journal:  J Viral Hepat       Date:  2014-05       Impact factor: 3.728

6.  Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants.

Authors:  Khaled AbdulQawi; Ahmed Youssef; Mohamed A Metwally; Ibrahim Ragih; Mohamed AbdulHamid; AbdulAziz Shaheen
Journal:  Croat Med J       Date:  2010-06       Impact factor: 1.351

7.  Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients.

Authors:  E Y Ho; N B Ha; A Ahmed; W Ayoub; T Daugherty; G Garcia; A Cooper; E B Keeffe; M H Nguyen
Journal:  J Viral Hepat       Date:  2011-10-07       Impact factor: 3.728

8.  Seroprevalence and risk factors for hepatitis B and C virus infection in Damietta Governorate, Egypt.

Authors:  A Edris; M O Nour; O O Zedan; A E Mansour; A A Ghandour; T Omran
Journal:  East Mediterr Health J       Date:  2014-10-20       Impact factor: 1.628

9.  Hepatitis c in a community in Upper Egypt: risk factors for infection.

Authors:  Ahmed Medhat; Magda Shehata; Laurence S Magder; Nabiel Mikhail; Laila Abdel-Baki; Mohamed Nafeh; Mohamed Abdel-Hamid; G Thomas Strickland; Alan D Fix
Journal:  Am J Trop Med Hyg       Date:  2002-05       Impact factor: 2.345

10.  Correlates of HCV seropositivity among familial contacts of HCV positive patients.

Authors:  Giuseppe La Torre; Luca Miele; Alice Mannocci; Giacomina Chiaradia; Filippo Berloco; Maria L Gabrieli; Giovanni Gasbarrini; Maria Giovanna Ficarra; Antonio Matera; Gualtiero Ricciardi; Antonio Grieco
Journal:  BMC Public Health       Date:  2006-09-25       Impact factor: 3.295

View more
  2 in total

Review 1.  Genomics in Egypt: Current Status and Future Aspects.

Authors:  Eman Ahmed El-Attar; Rasha Mohamed Helmy Elkaffas; Sarah Ahmed Aglan; Iman S Naga; Amira Nabil; Hoda Y Abdallah
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

2.  Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study.

Authors:  Innocent Kamali; Dale A Barnhart; Jean d'Amour Ndahimana; Kassim Noor; Jeanne Mumporeze; Françoise Nyirahabihirwe; Jean de la Paix Gakuru; Tumusime Musafiri; Sandra Urusaro; Jean Damascene Makuza; Janvier Serumondo; Dina Denis Rwamuhinda; Maurice Nkundibiza; Fredrick Kateera; Gallican Rwibasira Nshogoza; Joel M Mubiligi
Journal:  PLoS One       Date:  2021-10-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.